Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.

E. Melamed*, J. Zoldan, G. Friedberg, I. Ziv, A. Weizmann

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)545-550
Number of pages6
JournalAdvances in neurology
StatePublished - 1996
Externally publishedYes

Cite this